
## **Trustees’ Annual Report for the period** 

**From  January 2025   Period start date To  December 2025  Period end date** 

## **Charity registration number: 1190022** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|**The relief of poverty for the public**<br>**benefit in any part of the world through**<br>**the provision of advice, support,**<br>**equipment, treatment, and care to those**<br>**that suffers from osteogenesis**<br>**Imperfecta.**|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|**Educating the public and medical**<br>**professionals on the conditions through**<br>**seminars, conferences and raising**<br>**awareness on brittle bone condition.**|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|**Yes, the trustees confirm this. **|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers 



Other 

## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|**The charity has held a major OI**<br>**conference in the UK and in Nigeria,**<br>**Wheelchair distribution in Nigeria**<br>**covering over 4 different states and 9**<br>**local governments benefiting from the**<br>**distribution, with over 300 mobility**<br>**equipment supporting beneficiaries.**<br>**Several educational events on Zoom,**<br>**educating attendees about the brittle**<br>**bone conditions, signs to watch for and**<br>**where to get help if needed. Most**<br>**women globally have benefited from**<br>**these meetings.**<br>**We have also carried out training on**<br>**both brittle bone conditions and**<br>**disability in general to individuals,**<br>**church leadership on OI and disability**<br>**inclusion in worship and public places.**|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

||||
|---|---|---|
|Achievements against<br>objectives set|Para 1.41||
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|Investment performance<br>against objectives|Para 1.41||
|Other|||





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|**We received donations from individuals**<br>**and the church**|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|**The policy is to hold 3 months' worth of**<br>**expenditure as reserves**|
|Amount of reserves held|Para 1.22|**2.29 (balance from accounts at year end)**|
|Reasons for holding zero<br>reserves|Para 1.22||
|Details of fund materially in<br>deficit|Para 1.24|**N/A**|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|**-**|



|**Additional information (optional)**<br>You may choose to include further statements|**Additional information (optional)**<br>You may choose to include further statements|where relevant about:|
|---|---|---|
|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47|**Donation and fundraising**|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46|**None**|
|A description of the principal<br>risks facing the charity|Para 1.46|**_**|
|Other|||





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|**Constitution**|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|**CIO**|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|**Appointed by trustees**|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

||||
|---|---|---|
|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51||
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51||
|Relationship with any related<br>parties|Para 1.51||
|Other|||



## **Reference and Administrative details** 

|Charity name|Osteogenesis Imperfecta Foundation Network|
|---|---|
|Other name the charity uses|OIFN|
|Registered charity number|1190022|
|Charity’s principal address|74, Ladies Grove, St Albans, Herts, AL3 5TW.|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee(if any)**|
|---|---|---|---|---|
||Tarela Aghanti|Chair|For the wholeyear||
||Blandine Davis|Treasurer|For the wholeyear||
||Caroline Harrigan|Sec|For the wholeyear||
||Maureen<br>Whitehead|Trustee|For the whole year||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



– Corporate trustees names of the directors at the date the report was approved 

**Director name** 

Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|**N/A**|||
||||
||||
||||
||||
||||





## **Funds held as custodian trustees on behalf of others** 

Description of the assets N/A held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Type of**|**Name**|**Address**|
|---|---|---|
|**adviser**|||



**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

**N/A** 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s)** Tarela Aghanti **Full name(s)** Tarela Aghanti **Position (eg Secretary,** Chair **Chair, etc) Date** 29/01/2025 



||<br>**OSTEOGENESIS IMPERFECTA FOUNDATION NETWORK**|<br>**OSTEOGENESIS IMPERFECTA FOUNDATION NETWORK**|<br>**OSTEOGENESIS IMPERFECTA FOUNDATION NETWORK**|<br>**OSTEOGENESIS IMPERFECTA FOUNDATION NETWORK**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|01/01/2025|**To**<br>|||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**1,012**<br>**2,597**<br>**290**<br>**2,903**<br>**475**<br>**249**<br>**-**<br>**-**<br> <br> **7,526**<br>**-**<br>**-**<br> **-**<br>**7,526**<br>**275**<br>**122**<br>**279**<br>**4,430**<br>**35**<br>**1,290**<br>**1,094**<br>**-**<br>**-**<br> **7,525**<br>**-**<br>**-**<br> **-**<br>**7,525**<br>**1**<br>**-**<br>**1**<br>**2**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**1,012**<br>**2,597**<br>**290**<br>**2,903**<br>**475**<br>**249**<br>**-**<br>**-**<br>**7,526**<br>**-**<br>**-**<br>**-**<br>**7,526**<br>**275**<br>**122**<br>**279**<br>**4,430**<br>**35**<br>**1,290**<br>**1,094**<br>**-**<br>**-**<br>**7,525**<br>**-**<br>**-**<br>**-**<br>**7,525**<br>**1**|**Last year**<br>**to the nearest £**|
|GIFTS-INDIVIDUAL|**1,012**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**-**|
|Conference Fes|**2,597**||||**-**|
|Advertisements|**290**||||**-**|
|Donations|**2,903**||||**-**|
|Logistics|**475**||||**-**|
|Aid Received|**249**||||**-**|
||**-**||||**-**|
||**-**||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|<br> **7,526**||||**-**|
|||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||
||**-**||**-**<br>**-**<br>**-**|||
||**-**||||**-**|
|**_Sub total_**|**-**||||**-**|
|**_Total receipts_**<br>**A3 Payments**||||||
||||**-**||**-**|
|||||||
|<br>Insurance|**275**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**-**|
|Telephone|**122**||||**-**|
|Computer Supplies and Equipment|**279**||||**-**|
|Trainingand Conferernce|**4,430**||||**-**|
|Transport|**35**||||**-**|
|Grants-Clients and others|**1,290**||||**-**|
|Miscellaneous and bank fees|**1,094**||||**-**|
||**-**||||**-**|
||**-**||||**-**|
|**_Sub total_ **|**7,525**||||**-**|
|||||||
|**A4 Asset and investment**<br>**purchases (see table)**||||||
|**,**|**-**||**-**<br>**-**<br>**-**|||
||**-**|||||
|**_Sub total_ **|**-**||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||
||||**-**||**-**|
|||||||
||**1**||<br>**-**||**-**|
||**-**||**-**<br>**-**|**-**<br>**1**|**-**|
||**1**||||**-**|
||**2**||<br>**-**|**2**|**-**|



CCXX R1 accounts (SS) 

29/01/2026 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>**Details**<br>Signature|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Agreement Error<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||||
|||||



CCXX R2 accounts (SS) 

29/01/2026 

2 

